CIBC Private Wealth Group
IMMU

CIBC Private Wealth Group’s Immunomedics Inc IMMU Stock Holding History

CIBC Private Wealth Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-75,507
Closed -$6.42M – 1023
2020
Q3 		$6.42M Sell
75,507
-26,739
-26% -$1.35M 0.02% 341
2020
Q2 		$3.62M Sell
102,246
-7,099
-6% -$208K 0.02% 325
2020
Q1 		$1.47M Buy
109,345
+3,913
+4% +$65.8K 0.01% 458
2019
Q4 		$2.23M Buy
105,432
+13,908
+15% +$245K 0.01% 452
2019
Q3 		$1.21M Sell
91,524
-14,603
-14% -$215K ﹤0.01% 540
2019
Q2 		$1.47M Buy
106,127
+5,325
+5% +$80.1K 0.01% 513
2019
Q1 		$1.94M Buy
100,802
+7,790
+8% +$126K 0.01% 469
2018
Q4 		$1.33M Buy
93,012
+5,172
+6% +$103K 0.01% 516
2018
Q3 		$1.83M Hold
87,840
– – 0.01% 529
2018
Q2 		$2.08M Sell
87,840
-1,452
-2% -$29.2K 0.01% 482
2018
Q1 		$1.3M Buy
89,292
+13,427
+18% +$219K 0.01% 598
2017
Q4 		$1.23M Sell
75,865
-95
-0.1% -$1.12K 0.01% 615
2017
Q3 		$1.06M Buy
75,960
+28,635
+61% +$285K ﹤0.01% 625
2017
Q2 		$418K Sell
47,325
-45,300
-49% -$318K ﹤0.01% 549
2017
Q1 		$599K Buy
+92,625
New +$469K ﹤0.01% 503

CIBC Private Wealth Group's IMMU Position: Q4 2020 in Review

CIBC Private Wealth Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 75,507 shares — an estimated $6.42M sold.

CIBC Private Wealth Group first reported a position in IMMU in Q1 2017 and held it in 15 quarters. The position peaked at $6.42M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • CIBC Private Wealth Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • CIBC Private Wealth Group sold 75,507 Immunomedics Inc shares in Q4 2020, an estimated $6.42M.
  • CIBC Private Wealth Group first reported a position in Immunomedics Inc in Q1 2017 and held it in 15 quarters.
  • CIBC Private Wealth Group's Immunomedics Inc position peaked at $6.42M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on CIBC Private Wealth Group's 13F filing for Q4 2020, filed 12 Feb 2021.